Accumulation of wild-type α-synuclein decreases mitochondrial complex I activity and increases the production of ROS in the mitochondria of human dopaminergic neurons and in the PD brain [101] as supported by the fact that the protein can promote mitochondrial deficits and oxidative stress [102]. Here, SNCA is linked to Parkinson disease.